Related Experiment Video
Updated: Jul 16, 2026
03:19
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
A practical approach to maternal phenylketonuria management
1Charles Dent Metabolic Unit, The National Hospital for Neurology and Neurosurgery, London, UK. francois.maillot@uclh.nhs.uk
Journal of Inherited Metabolic Disease
|March 14, 2007
Summary
Managing phenylketonuria in pregnancy is crucial for fetal health. This involves strict phenylalanine control, dietary adjustments, and close monitoring to prevent developmental issues and birth defects.
Area of Science:
- Metabolic disorders
- Maternal-fetal medicine
- Neurodevelopmental disorders
Background:
- Increasing pregnancies among women with phenylketonuria (PKU) necessitate specialized management.
- Elevated phenylalanine levels pose significant risks to fetal development, including dysmorphism and cognitive impairment.
Purpose of the Study:
- To describe single-center experiences in managing PKU pregnancies over nearly three decades.
- To illustrate key management strategies for women with PKU planning or experiencing pregnancy.
Main Methods:
- Presentation of a six-case series to highlight management principles.
- Emphasis on pre-conception dietary intervention and rapid phenylalanine reduction when necessary.
- Monitoring of blood phenylalanine (100-250 micromol/L), maternal weight, and micronutrients.
Main Results:
- Successful maintenance of target phenylalanine levels is achievable with diligent monitoring and dietary adjustments.
- Increased phenylalanine tolerance during pregnancy requires prompt dietary increases.
- Postnatal follow-up includes infant neurological and cardiac assessments, with long-term neurodevelopmental evaluations for offspring.
Conclusions:
- Effective management of PKU in pregnancy requires a multidisciplinary approach and consistent monitoring.
- Early and ongoing intervention is vital for optimizing maternal and fetal outcomes in PKU pregnancies.
- Long-term follow-up of both mother and child is essential for assessing developmental trajectories and managing PKU effectively.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...